Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 19/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24415034 | 0.88 | TLR7 (0.39) | TLR7MAOBHTR6 | |
| SCHEMBL1074029 | 0.88 | TLR7 (0.42) | TLR7MAOBHTR6 | |
| SCHEMBL30851335 | 0.84 | TLR7 (0.65) | TLR7 | |
| SCHEMBL20796977 | 0.84 | TLR7 (0.65) | TLR7 | |
| SCHEMBL14466065 | 0.81 | TLR7 (0.62) | TLR7 | |
| Hydrochloric Acid SCHEMBL4761666 | 0.81 | TLR7 (0.61) | TLR7 | |
| SCHEMBL24415342 | 0.80 | TLR7 (0.41) | TLR7 | |
| SCHEMBL24415020 | 0.80 | TLR7 (0.43) | TLR7 | |
| SCHEMBL20796917 | 0.80 | SMN1; SMN2 (0.42) | TLR7 | |
| SCHEMBL1949364 | 0.80 | TLR7 (0.47) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144822-A1 | PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOQUINOLINE | BioNTech SE (DE) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144822-A1 | PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOQUINOLINE | TLR7, TLR3, TLR4 | TLR7 1/4885MAOB 2269/4885HTR6 811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.